What regulatory guidelines apply to N-[(1R,2R,6S,7S,8S,10R)-3,5-Dioxo-4-azatetracyclo[5.3.2.0~2,6~.0~8,10~]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide (CAS: 816458-31-8)?

The compound N-[(1R,2R,6S,7S,8S,10R)-3,5-Dioxo-4-azatetracyclo[5.3.2.0~2,6~.0~8,10~]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide (CAS: 816458-31-8) falls under the scope of several regulatory guidelines. It is subject to the REACH regulations in the European Union, which require documentation of its potential environmental, health, and safety impacts. Additionally, it must comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for proper hazard communication. In the United States, it is regulated by the EPA and FDA for environmental and pharmaceutical applications, respectively. Compliance with these guidelines is essential for safe handling and use.